Literature DB >> 9693060

Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.

K J Potter1, M A Bevins, E V Vassilieva, V R Chiruvolu, T Smith, L A Smith, M M Meagher.   

Abstract

A recombinant Hc fragment of botulinum neurotoxin, serotype B (rBoNTB(Hc)), has been successfully expressed in a Mut+ strain of the methylotrophic yeast Pichia pastoris for use as an antigen in a proposed human vaccine. The fermentation process consisted of batch phase on glycerol, followed by glycerol and methanol fed-batch phases yielding a final cell mass of 60 g/L (dcw) and was easily scaled-up to 60 L. A multistep ion-exchange chromatographic purification process was employed to produce 99% pure Hc fragment. The final yield of the purified antigen was 390 mg per kilogram of wet cell mass. The purified Hc fragment of serotype B was stable, elicited an immune response in mice, and protected upon challenge with native botulin. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693060     DOI: 10.1006/prep.1998.0910

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles.

Authors:  Tinashe B Ruwona; Haiyue Xu; Junwei Li; Diana Diaz-Arévalo; Amit Kumar; Mingtao Zeng; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

2.  Expression of HC subunits from Clostridium botulinum types C and D and their evaluation as candidate vaccine antigens in mice.

Authors:  L A Woodward; H Arimitsu; R Hirst; K Oguma
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.

Authors:  YunZhou Yu; DanYang Shi; Si Liu; Zheng-Wei Gong; Shuang Wang; ZhiWei Sun
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: evaluation of suitable purification process conditions.

Authors:  Frank K Bedu-Addo; Catharine Johnson; Shanthini Jeyarajah; Ian Henderson; Siddharth J Advant
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 5.  Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.

Authors:  Laura M Zarebski; Kerrie Vaughan; John Sidney; Bjoern Peters; Howard Grey; Kim D Janda; Arturo Casadevall; Alessandro Sette
Journal:  Expert Rev Vaccines       Date:  2008-02       Impact factor: 5.217

Review 6.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

7.  Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris.

Authors:  Cemal Gurkan; David J Ellar
Journal:  Microb Cell Fact       Date:  2005-12-07       Impact factor: 5.328

8.  Characterization and immunological activity of different forms of recombinant secreted Hc of botulinum neurotoxin serotype B products expressed in yeast.

Authors:  Bo Liu; DanYang Shi; ShaoHong Chang; Xin Gong; YunZhou Yu; ZhiWei Sun; Jun Wu
Journal:  Sci Rep       Date:  2015-01-08       Impact factor: 4.379

Review 9.  Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-12-22       Impact factor: 4.546

10.  Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.

Authors:  Robert P Webb; Theresa J Smith; Leonard A Smith; Patrick M Wright; Rebecca L Guernieri; Jennifer L Brown; Janet C Skerry
Journal:  Toxins (Basel)       Date:  2017-09-03       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.